share_log

Allarity Therapeutics | DEFA14A: Others

Allarity Therapeutics | DEFA14A: Others

Allarity Therapeutics | DEFA14A：其他
美股SEC公告 ·  2024/07/26 18:09

Moomoo AI 已提取核心訊息

Allarity Therapeutics, Inc. has announced the postponement of its 2024 Annual Meeting of Stockholders, which was originally scheduled for July 26, 2024. The decision to delay the meeting was made by the company's board of directors on July 25, 2024, one day before the planned event. The board cited the company's bylaws as the basis for their authority to reschedule the meeting. A new date for the Annual Meeting has yet to be determined, but the board will establish this date and, if necessary, a new record date for stockholder voting eligibility. The company will issue a notice and, if applicable, an updated Proxy Statement to all eligible stockholders based on the original record date of June 14, 2024, or a new record date. This information was provided in a supplement to the Proxy Statement filed with the Securities and Exchange Commission on July 1, 2024. Allarity Therapeutics has urged stockholders to review the Proxy Statement and other relevant documents filed with the SEC for more information regarding the Annual Meeting and the matters to be voted on.
Allarity Therapeutics, Inc. has announced the postponement of its 2024 Annual Meeting of Stockholders, which was originally scheduled for July 26, 2024. The decision to delay the meeting was made by the company's board of directors on July 25, 2024, one day before the planned event. The board cited the company's bylaws as the basis for their authority to reschedule the meeting. A new date for the Annual Meeting has yet to be determined, but the board will establish this date and, if necessary, a new record date for stockholder voting eligibility. The company will issue a notice and, if applicable, an updated Proxy Statement to all eligible stockholders based on the original record date of June 14, 2024, or a new record date. This information was provided in a supplement to the Proxy Statement filed with the Securities and Exchange Commission on July 1, 2024. Allarity Therapeutics has urged stockholders to review the Proxy Statement and other relevant documents filed with the SEC for more information regarding the Annual Meeting and the matters to be voted on.
Allarity Therapeutics, Inc.宣佈推遲其原定於2024年7月26日舉行的2024年股東年會。董事會於2024年7月25日在計劃活動前一天做出了延遲舉行會議的決定。董事會以公司章程爲基礎，宣佈有權重新安排會議。股東年會的新日期尚未確定，但董事會將確定此日期，並根據需要確定新的股東投票資格記錄日期。該公司將向所有符合資格的股東發佈通知，並在原始記錄日期爲2024年6月14日或新記錄日期的基礎上，如果適用，發佈更新的委託書聲明。此信息是在2024年7月1日提交給證券交易委員會的委託書聲明補充中提供的。Allarity Therapeutics敦促股東查閱提交給SEC的委託書聲明和其他相關文件，以獲取有關股東年會和議題的更多信息。
Allarity Therapeutics, Inc.宣佈推遲其原定於2024年7月26日舉行的2024年股東年會。董事會於2024年7月25日在計劃活動前一天做出了延遲舉行會議的決定。董事會以公司章程爲基礎，宣佈有權重新安排會議。股東年會的新日期尚未確定，但董事會將確定此日期，並根據需要確定新的股東投票資格記錄日期。該公司將向所有符合資格的股東發佈通知，並在原始記錄日期爲2024年6月14日或新記錄日期的基礎上，如果適用，發佈更新的委託書聲明。此信息是在2024年7月1日提交給證券交易委員會的委託書聲明補充中提供的。Allarity Therapeutics敦促股東查閱提交給SEC的委託書聲明和其他相關文件，以獲取有關股東年會和議題的更多信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間